Question 14 · LEK · Hepatitis B
Indicate the true statement concerning the rules and time in the treatment for chronic hepatitis B:
- A. chronic hepatitis B should be treated with pegylated interferon.
- B. chronic hepatitis B should be life-long treated with lamivudine in each HBsAg-positive patient.
- C. chronic hepatitis B should be treated with entecavir or tenofovir for 48 weeks.
- D. chronic hepatitis B should be treated with pegylated interferon for 48 weeks in selected patients or with entecavir or tenofovir until the elimination of HBs antigen and the occurrence of anti-HBs antibodies.
- E. chronic hepatitis B does not demand any antiviral treatment nowadays.
Hint
Distinguish finite immunomodulatory therapy from long-term viral suppression, and recall the endpoint that allows stopping the latter.
The answer, the explanation and a note on every option are available once you log in. The account is free: topic tests, a mock exam, mistake review and statistics.
More questions on Internal medicine
- Which of the following factors increase the risk of community-acquired pneumonia?
- The measurement of albuminuria in 24 h urine collection may be replaced by more convenient:
- Indicate the laboratory test used to determine if ascites is caused by portal hypertension:
- Interstitial pneumonia:
- The first-choice medication in the treatment of skin itching caused by cholestasis is:
- A 58-year-old man otherwise healthy, not treated for any chronic diseases complains of chronic constipation. He was admitted to the hospital because…